KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Gilead Sciences (GILD) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $2.7 billion.

  • Gilead Sciences' Accumulated Depreciation & Amortization changed N/A to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year change of. This contributed to the annual value of $2.5 billion for FY2024, which is 85.75% up from last year.
  • As of Q3 2025, Gilead Sciences' Accumulated Depreciation & Amortization stood at $2.7 billion.
  • Over the past 5 years, Gilead Sciences' Accumulated Depreciation & Amortization peaked at $2.7 billion during Q3 2025, and registered a low of $1.9 billion during Q4 2021.
  • Over the past 5 years, Gilead Sciences' median Accumulated Depreciation & Amortization value was $2.5 billion (recorded in 2024), while the average stood at $2.4 billion.
  • Per our database at Business Quant, Gilead Sciences' Accumulated Depreciation & Amortization surged by 1547.81% in 2022 and then skyrocketed by 85.75% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Accumulated Depreciation & Amortization stood at $1.9 billion in 2021, then grew by 15.48% to $2.2 billion in 2022, then rose by 12.03% to $2.4 billion in 2023, then increased by 0.86% to $2.5 billion in 2024, then increased by 9.03% to $2.7 billion in 2025.
  • Its last three reported values are $2.7 billion in Q3 2025, $2.6 billion for Q2 2025, and $2.5 billion during Q1 2025.